Arundathy N. Pandite - Jan 10, 2022 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Role
Chief Medical Officer
Signature
/s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite
Stock symbol
STTK
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
4
Date filed
1/12/2022, 05:45 PM
Previous filing
Aug 18, 2021
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STTK Common Stock Award $0 +34.7K +32.72% $0.00 141K Jan 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STTK Stock Option (Right to Buy) Award $0 +69.5K $0.00 69.5K Jan 10, 2022 Common Stock 69.5K $7.43 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer.
F2 This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer.